Prioritizing VELDONA®'s development for oral warts in HIV+ patients and Sjogren's syndromeBurgeoning pet care market also presents growth opportunities for VELDONA® SAN DIEGO, CA / ACCESSWIRE / Octobe ...
After 68 clinical studies across 16 indications with approximately 6,000 trial participants, VELDONA® demonstrated a strong safety profile compared to injectable versions, with notable clinical ...
The fight against common warts is gaining momentum, with the Common Warts Market projected to reach a value of USD 1.100 million by 2033. This forecast, according to a new report by Future Market ...
Special Conference: Tumor Immunology and Immunotherapy: New immunology data showed ability of INO-3107 to induce an antigen-specific T cell response against HPV-6 and HPV-11 and drive recruitment of ...